adapalene and Acne
adapalene has been researched along with Acne in 227 studies
Research
Studies (227)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (11.89) | 18.2507 |
| 2000's | 86 (37.89) | 29.6817 |
| 2010's | 81 (35.68) | 24.3611 |
| 2020's | 33 (14.54) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Arlabosse, JM; Bouix-Peter, C; Chambon, S; Chantalat, L; Daver, S; Dumais, L; Duvert, G; Feret, A; Ouvry, G; Pascau, J; Portal, T; Raffin, C; Rodeville, N; Soulet, C; Tabet, S; Talano, S; Thoreau, E | 1 |
| Baldwin, H; Beer, K; Bhatt, V; Callender, V; Draelos, Z; Gold, M; Kircik, LH; Lain, E; Pariser, DM; Pillai, R; Sadick, N; Stein Gold, L; Tanghetti, EA; Weiss, JS | 1 |
| Maruthappu, T; Taylor, M | 1 |
| Griffin, S; Mallavalli, S; Meckfessel, M; Wagner, N; Weiss, J | 1 |
| Anaya-Ruiz, M; Perez-Santos, M | 1 |
| Ishida, T; Saito, R; Takahagi, S; Tanaka, A | 1 |
| Ebell, MH | 1 |
| Abdel-Wahab, HM; Ali, AK; Ragaie, MH | 1 |
| Asawanonda, P; Kumtornrut, C; Noppakun, N; Paemanee, A; Pewlong, P; Pongpamorn, P; Sirikantaramas, S; Wongtada, C | 1 |
| Chatim, A; Feldman, S; Kankaria, A; Singh, R | 1 |
| Chavda, R; Dréno, B; Layton, AM; Rocha, M; Troielli, P | 1 |
| Auffret, N; Ballanger, F; Claudel, JP; Dreno, B; Leccia, MT | 1 |
| Draelos, ZD | 1 |
| Abd-Allah, H; Elmowafy, E; Ragaie, MH | 1 |
| Baalbaki, N; Colon, G; Draelos, ZD; Dreno, B | 1 |
| Bhatia, N; Draelos, ZD; Kircik, LH; Stein Gold, L; Sugarman, JL; Tanghetti, EA; Zeichner, JA | 1 |
| Abe, M; Hayashi, N; Tanizaki, H | 1 |
| Barbieri, JS; Shields, A | 1 |
| Duo, K; Liu, L; Xin, C; Yu, X | 1 |
| Nasir, A | 1 |
| Demessant-Flavigny, A; Dréno, B; Kerob, D; Khammari, A; Seité, S | 1 |
| Janani, SK; Karthika, C; Sureshkumar, R; Upadhyayula, SSN; Vasanthi, C | 1 |
| Dubey, A; El-Zahaby, SA; G S, R; Ghate, VM; Hebbar, S; Lewis, SA; Vasanth, S | 1 |
| Abdelmaksoud, A; Galadari, H; Goldust, M; Grabbe, S; Gupta, M; Karagaiah, P; Kassir, M; Katsambas, A; Lotti, T; Sonthalia, S; Wollina, U | 1 |
| Abd-Elaziz, H; Abd-Elrazek, H; Abdo, H; Amer, M; Bakr, E | 1 |
| Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H | 1 |
| Fukumoto, T; Fukunaga, A; Nishigori, C; Sugiyama, M | 1 |
| Aguiar, MMG; Alves, CPB; Ferreira, LAM; Goulart, GAC; Lima, FA; Martins-Santos, E; Oliveira, CA; Oréfice, RL; Rodrigues, LBO | 1 |
| Ahmad Nasrollahi, S; Firooz, A; Koohestani, F; Naeimifar, A; Samadi, A; Vatanara, A | 1 |
| Fuchs, CSK; Haedersdal, M; Hansen, FS; Ortner, VK; Philipsen, PA | 1 |
| Emam, M; Mohammad Soleymani, S; Salimi, A | 1 |
| Bucher, HC; Finlay, AY; Layton, AM; Little, P; Maund, E; Newell, D; Regas, C; Santer, M; Sivaramakrishnan, G; Soulsby, I; Sridharan, K; Stuart, B; Tang, KF; Wilcox, C | 1 |
| Emmerich, VK; Feldman, SR; Purvis, CG | 1 |
| Amani, A; Ehsani, A; Eslami Farsani, V; Jafarzadeh Kohneloo, A; Mehdizade Rayeni, N; Moghimi, HR; Najafi-Taher, R | 1 |
| Bouloc, A; Chadoutaud, B; Dréno, B; Imko-Walczuk, B; Moga, A; Roo, E | 1 |
| Marín Boscá, MT; Sallam, MA | 1 |
| Ashique Rahman, MA; Hota, D; Maiti, R; Parida, S; Sirka, CS; Srinivasan, A | 1 |
| Lee, JK; Smith, AD | 1 |
| Baldwin, H; Del Rosso, JQ; Johnson, SM; Lain, EL; Landis, M; Rendon, M; Rueda, MJ; Stein Gold, L; Tanghetti, E; Weiss, J | 1 |
| Barankin, B; Bissonnette, R; Dréno, B; Gagné-Henley, A; Kerrouche, N; Lynde, C; Tan, J | 1 |
| Akamatsu, H; Furukawa, F; Furumura, M; Hayashi, N; Iwatsuki, K; Kaminaka, C; Kawashima, M; Kobayashi, M; Kono, T; Kurokawa, I; Miyachi, Y; Shimada-Omori, R; Tanioka, M; Yamamoto, Y; Yamasaki, K; Yamasaki, O | 1 |
| Chlebus, E; Chlebus, M; Serafin, M | 1 |
| Endo, A; Hatanaka, T; Hayashi, N; Kawashima, M; Kurokawa, I; Siakpere, O; Yamada, M | 1 |
| Jain, S; Kale, DP; Katiyar, SS; Swami, R | 1 |
| Cárdenas, C; Hasson, A; Nicklas, C; Rubio, R | 1 |
| Chen, J; Lai, W; Xia, Y; Ye, C; Yin, S; Zeng, Q; Zheng, Y | 1 |
| Bitner, B; Harris, B; Thomas, L | 1 |
| Chayahara, N; Doi, H; Fujishima, Y; Fukunaga, A; Kawaguchi, A; Kiyota, N; Kobayashi, K; Marugami, N; Minami, H; Mizuta, N; Mukohara, T; Nakata, K; Nishigori, C; Nishimura, Y; Tachihara, M; Takenaka, K; Tobimatsu, K; Toyoda, M; Washio, K; Yamamoto, M | 1 |
| Furukawa, F; Ito, T; Noguchi, N; Shimada, S; Takigawa, M; Tokura, Y | 1 |
| Bonifaz, A; Espíndola, YS; Ponce-Olivera, RM; Tirado-Sánchez, A | 1 |
| Draelos, Z; Eichenfield, LF; Hebert, AA; Liu, H; Lucky, AW; Manna, V; Rudisill, D; Stein Gold, L; Sugarman, J | 1 |
| Grove, G; Gwazdauskas, J; Zerweck, C | 1 |
| Babaeinejad, SH; Fouladi, RF | 2 |
| Bettoli, V; Borghi, A; Giari, S; Ricci, M; Toni, G; Virgili, A; Zauli, S | 1 |
| Elliott, L; Fisher, S; Kobraei, K; Lessner, E; Lessner, R; Osleber, M; Wesson, S | 1 |
| Feldman, SR; Gustafson, CJ; Huang, KE; Levender, MM; Sandoval, LF; Semble, A | 1 |
| Alexis, AF; Callender, VD; Johnson, LA; Kerrouche, N | 1 |
| Fan, A; Guo, C; Khengar, RH; Sun, M; Wang, Z; Zhao, Y | 1 |
| Hayashi, N; Kawashima, M | 2 |
| Audibert, F; Barankin, B; Gooderham, M; Humphrey, S; Kerrouche, N; Lynde, C; Tan, J; Vender, R | 1 |
| Agarwal, A; Agrawal, GP; Agrawal, H; Garg, NK; Jain, A; Jain, AK; Jain, RK; Jain, SA; Tyagi, RK | 1 |
| Furukawa, F; Kaminaka, C; Kanazawa, N; Kuramoto, T; Yamamoto, Y; Yoshimasu, T | 1 |
| Gollnick, H; Kropf, S; Lux, A; Papakonstantinou, E; Thielitz, A; Wiede, A | 1 |
| Jo, R; Kobayashi, Y; Numata, T; Okubo, Y; Tsuboi, R | 1 |
| Funke, G; Gollnick, HP; Jäckel, A; Jöstingmeyer, P; Kors, C; Titzmann, T | 1 |
| Friedrich, M; Gollnick, HP; Jäckel, A; Jöstingmeyer, P; Peschen, M; Pettker, R; Pier, A; Porombka, D; Rojo Pulido, I; Streit, V | 2 |
| Chularojanamontri, L; Kulthanan, K; Tuchinda, P; Varothai, S; Winayanuwattikun, W | 1 |
| Garg, NK; Jain, A; Jain, AK; Kesharwani, P; Nirbhavane, P; Tyagi, RK | 1 |
| Leoni, M; Liu, H; Rueda, MJ; Stein Gold, L; Tanghetti, E; Weiss, J | 1 |
| Liu, H; Rueda, MJ; Stein Gold, L; Tanghetti, E; Weiss, J | 1 |
| Leyden, J | 3 |
| Banga, AK; Kumar, V | 1 |
| Dressler, C; Nast, A; Rosumeck, S | 1 |
| Bhatia, N; Bhatt, V; Martin, G; Pillai, R | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Bonati, LM; Silverberg, NB; Yeh, L | 1 |
| Ditre, CM; Rattanaumpawan, P; Tangjaturonrusamee, C | 1 |
| Michniak-Kohn, BB; Ramezanli, T; Zhang, Z | 1 |
| Kawada, A; Kurokawa, I; Oiso, N | 1 |
| Bikowski, J; Del Rosso, JQ | 1 |
| Fleischman, D; Givre, SJ | 1 |
| Del Rosso, JQ | 4 |
| Arsonnaud, S; Soto, P; Thiboutot, D | 1 |
| Colón, LE; Gottschalk, RW; Johnson, LA; Pariser, D | 1 |
| Colón, LE; Gold, LS; Gottschalk, RW; Johnson, LA | 1 |
| Grossman, R; Leyden, JJ; Nighland, M | 1 |
| Feldman, SR; Irby, CE; Yentzer, BA | 1 |
| Gollnick, H; Thielitz, A | 1 |
| Baldwin, EK; Leyden, J; Wortzman, M | 1 |
| Ghali, F; Kang, S; Leyden, J; Shalita, AR; Thiboutot, DM | 1 |
| Kim, MB; Ko, HC; Kwon, KS; Oh, CK; Seo, SH; Song, M | 1 |
| Cornelison, R; Draelos, Z; Glenn, MJ; Gollnick, HP; Gore, B; Graeber, M; Kaszuba, A; Liu, Y; Rosoph, LA | 1 |
| Miyai, E; Sugino, K | 1 |
| Cruz-Santana, A; Gidner, J; Gold, LS; Graeber, M; Liu, Y; Papp, K; Poulin, Y; Schlessinger, J; Tan, J | 1 |
| Eady, EA; Layton, AM | 1 |
| Alió, AB; Barnard, J; Fischer, TC; Wohlrab, J; Zouboulis, CC | 1 |
| Abramovits, W; Eichenfield, LF; Fleischer, AB; Garrett, S; Lucky, A; Shalita, A | 1 |
| Cruz, A; Dhuin, JC; Eichenfield, L; Gold, LS; Jorizzo, J; Kerrouche, N; Tan, J | 1 |
| Baliga, VP; Dhurat, R; Dongre, P; Ghosh, S; Rao, GR; Sharma, A | 1 |
| Barnett, P; Del Rosso, J; Dhawan, S; Draelos, Z; Glaser, DA; Green, L; Grimes, P; Le Gall, N; Leyden, J; Shalita, A; Tanghetti, E; Webster, G | 1 |
| Eichenfield, LF; Graeber, M; Hwa, J; Jarratt, M; Kempers, S; Liu, Y; Manna, V; Schlessinger, J | 1 |
| Gold, LS; Gollnick, HP; Loesche, C; Ma, YM; Tan, J | 1 |
| Leyden, JJ; Nighland, M; Ramaswamy, R; Rossi, AB | 1 |
| Dirschka, T; Eichenfield, LE; Graeber, M; Jorizzo, JL; Kerrouche, N; Lynde, C; Taub, AF | 1 |
| Bettoli, V; Borghi, A; Giari, S; Mantovani, L; Minghetti, S; Virgili, A | 1 |
| Hansen, SR; Kroon, S; Mikkelsen, CS | 1 |
| Katsuura, J; Kubota, Y; Matsunaka, H; Moriue, T; Munehiro, A; Murakami, Y; Nakai, K; Shirahige, Y; Yoneda, K | 1 |
| Balkrishnan, R; Camacho, FT; Clark, AR; Colón, LE; Feldman, SR; Fleischer, AB; Fountain, JM; Gosnell, AL; Johnson, LA; Pearce, DJ; Preston, N; Yentzer, BA; Young, TA | 1 |
| Dirschka, T; Feldman, SR; Kerrouche, N; Manna, V; Poulin, Y; Tan, J | 1 |
| Bucko, A; Dhuin, JC; Fowler, J; Jarratt, M; Kempers, S; Kerrouche, N; Kunynetz, R; Poulin, Y; Sanchez, NP | 1 |
| Berg, M; Bettoli, V; De Maubeuge, J; Dréno, B; Foley, P; Gómez-Flores, M; Kaufmann, R; Kerrouche, N; Paliargues, F; Rodríguez-Castellanos, MA; Sysa-Jedrzejowska, A; Talarico, S; Torres Lozada, V | 1 |
| Fluhr, JW; Nast, A | 1 |
| Kubota, Y; Matsunaka, H; Moriue, T; Munehiro, A; Murakami, Y; Nakai, K; Shirahige, Y; Yoneda, K | 1 |
| Chaussy, H; Dréno, B; Khammari, A; Knol, AC; Zuliani, T | 1 |
| Keating, GM | 1 |
| Fukamachi, K; Kobayashi, M; Nakagawa, T; Nakamura, M; Tokura, Y | 1 |
| Brodell, RT; Bucher, D; Kerrouche, N; Rafal, E; Schlosser, BJ; Toth, D; Tyring, S; Wertheimer, A | 1 |
| Brodell, R; Cruz, A; Jarratt, M; Jones, T; Kerrouche, N; Schlessinger, J; Stein Gold, L; Tan, J | 1 |
| Borelli, C; Burgdorf, W; Mehra, T; Röcken, M; Schaller, M | 1 |
| Chan, R; Kerrouche, N; Leow, YH; Matsunaga, K; Paliargues, F | 1 |
| Guerra-Tapia, A | 1 |
| Caveney, SW; Feldman, SR; Fried, RG; Gottschalk, RW; Herndon, JH; Johnson, L; Preston, N | 1 |
| Ting, W | 1 |
| Cirigliano, M; Gonzalez, P; Vila, R | 1 |
| Kim, BS; Kim, MB; Kim, WJ; Ko, HC; Park, JM; Song, M | 1 |
| Ehst, BD; Goreshi, R; Samrao, A | 1 |
| Ioannides, D; Katsambas, A; Rigopoulos, D | 1 |
| Berger, RS; Grossman, RM; Jorizzo, JL; Kim, YH; Martin, AG; Nighland, M; Nyirady, J; Pandya, AG; Schulz, KK; Strauss, JS | 1 |
| Czernielewski, J; Mizzi, F; Poncet, M | 1 |
| Celi, E; Ng, CH; Schweitzer, I; Tam, MM; Tate, B | 1 |
| Liao, DC | 1 |
| Sardana, K; Sehgal, VN | 1 |
| Baker, MD; Czernielewski, J; Kaplan, D; Kraus, SJ; Liu, YS; Loven, KH; Rist, T; Swinyer, LJ; Wolf, JE | 1 |
| Alirezai, M; Briantais, P; Coutts, I; Cunliffe, WJ; George, SA; Hachem, JP; Meynadier, J; Roseeuw, DI; Sidou, F; Soto, P | 1 |
| Baker, MD; Brand, B; Georgeian, K; Gilbert, R; Greenspan, A; Poncet, M; Soloff, AM | 1 |
| de C Almeida, F; de Faria, FA; do Nascimento, LV; Guedes, AC; Guerra, RM; Magalhães, GM | 1 |
| Noble, S; Scott, LJ; Waugh, J | 2 |
| Biyun, C | 1 |
| Amerio, P; Capizzi, R; Landi, F; Milani, M | 1 |
| Leyden, JJ | 2 |
| Jain, S | 1 |
| Li, LF; Tu, YT; Zhang, JZ; Zheng, J | 1 |
| Korkut, C; Piskin, S | 1 |
| Arsonnaud, S; Dosik, JS; Homer, K | 1 |
| Purdy, S | 2 |
| Clark, SD; Graeber, M; Jones, TM; Liu, Y; Pariser, DM; Thiboutot, DM | 1 |
| Egan, N; Flores, J; Graeber, M; Herndon, JH; Hwa, J; Kanof, NB; Kempers, SE; Liu, Y; Maddin, S; Pariser, DM; Poulin, YP; Thiboutot, D; Wilson, DC | 1 |
| Arsonnaud, S; Dawson, C; Kang, S; Kerrouche, N; Shalita, AR; Thiboutot, DM; Yamauchi, PS | 1 |
| Campbell, JL; Weiss, JS | 2 |
| Gold, LS | 1 |
| Wolf, JE | 2 |
| Cook-Bolden, F | 1 |
| Gollnick, HP; Thiboutot, DM | 1 |
| DeWitt, CA; Siroy, AE; Stone, SP | 1 |
| Bragadin, G; Patrone, P; Pillon, B; Stinco, G; Trotter, D | 1 |
| Dreno, B; Khammari, A; Tenaud, I | 1 |
| Emtestam, L; Hagströmer, L; Nord, CE; Oprica, C | 1 |
| Gollnick, H; Sidou, F; Thielitz, A | 1 |
| Bucko, A; Clark, S; Eichenfield, L; Graeber, M; Jones, T; Kang, S; Liu, Y; Thiboutot, DM; Weiss, J | 1 |
| Kircik, L | 1 |
| Taylor, SC | 1 |
| Gold, MH; Graeber, M; Liu, Y; Morris, A; Pariser, DM; Westmoreland, P | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Ambroziak, M; Chu, A; Goulden, V; Langner, A | 1 |
| Harada, S; Kawashima, M; Loesche, C; Miyachi, Y | 1 |
| Andres, P; Pernin, C; Poncet, M | 1 |
| Bernard, BA | 1 |
| Baker, M; Chalker, DK; Czernielewski, J; Ellis, CN; Greenspan, A; Kantor, I; Katz, HI; Millikan, LE; Shalita, A; Swinehart, T; Swinyer, L; Weiss, JS; Whitmore, C | 1 |
| Alirezai, M; Czernielewski, J; Jablonska, S; Meynadier, J; Verschoore, M | 1 |
| Brogden, RN; Goa, KE | 1 |
| Caron, D; Clucas, A; Kerrouche, N; Sorba, V | 1 |
| Baker, M; Clucas, A; Czernielewski, J; Poncet, M; Sorba, V; Verschoore, M | 1 |
| Quan, MA; Strick, R; Usatine, RP | 1 |
| Allec, J; Chatelus, A; Michel, S; Shroot, B; Wagner, N | 1 |
| Bonardeaux, C; de la Brassinne, M | 1 |
| Shroot, B | 1 |
| Shavin, JS; Weiss, JS | 1 |
| Petersen, CS | 1 |
| Cunliffe, WJ | 1 |
| Démarchez, M; Jomard, A; Michel, S | 1 |
| Baker, MD; Dunlap, FE; Mills, OH; Plott, RT; Tuley, MR | 1 |
| Baker, MD; Dunlap, FE; Plott, RT; Verschoore, M | 1 |
| Alirezai, M; Clucas, A; Finlay, AY; Grosshans, E; Marks, R; Mascaro, JM; Meynadier, J; Poncet, M; Soto, P; Torras, H; Verschoore, M | 1 |
| Baker, M; Galvin, SA; Gilbert, R; Guibal, F; Tuley, MR | 1 |
| Baker, M; Berger, RS; Chalker, DM; Ellis, CN; Katz, IH; Loesche, C; Millikan, LE; Mills, OH; Smith, EB; Swinyer, LJ; Verschoore, M | 1 |
| Cunliffe, WJ; Loesche, C; Poncet, M; Verschoore, M | 1 |
| Fraiture, AL; Fumal, I; Henry, F; Piérard, GE; Piérard-Franchimont, C | 1 |
| Cornell, DH | 1 |
| Kakita, L | 1 |
| Draelos, Z; Kakita, L; Leyden, J; Lowe, N | 1 |
| Bershad, S | 1 |
| Gollnick, H | 1 |
| Kligman, A; Rizova, E | 1 |
| Millikan, LE | 1 |
| Li, GQ; Tu, P; Wong, WZ; Zheng, J; Zhu, XJ | 1 |
| Jacyk, WK | 1 |
| Shalita, A | 1 |
| Baker, M; Bouclier, M; Czernielewski, J; Hensby, JC; Michel, S | 1 |
| Baker, M; Gold, MH; Jarratt, MT; Kang, S; Kaplan, DL; Loesche, C; Millikan, L; Thiboutot, D; Wolfe, J | 1 |
| Baker, MM; Egan, N; Loesche, MC | 1 |
| Kligman, AM; Pagnoni, PA; Poncet, M; Rizova, E; Stoudemayer, T | 1 |
| Jones, TM; Jorizzo, JL; Kanof, NB; Loven, KH; Lucky, A; Miller, BH; Rodriguez, D; Stewart, DM; Tschen, EH; Wilson, DC | 1 |
| Baker, M; Busdiecker, FL; Herndon, JH; Slayton, RM; Tuley, M | 1 |
| Jacyk, WK; Mpofu, P | 1 |
| Duan, YQ; Tu, P; Zhen, J; Zhu, XJ | 1 |
| Guenther, L; Lee, J; Loven, K; Poulin, YP; Solomon, BA; Webster, GF | 1 |
| Czernielewski, J; Jablonska, S; Langner, A; Schaefer, H; Verschoore, M; Wolska, H | 1 |
| Bouclier, M; Chatelus, A; Delain, C; Ferracin, J; Hensby, CN; Shroot, B | 1 |
| Grandjean, L; Jamoulle, JC; Lamaud, E; Schaefer, BH; Shroot, B | 1 |
Reviews
49 review(s) available for adapalene and Acne
| Article | Year |
|---|---|
Acne and rosacea in skin of colour.
Topics: Acne Vulgaris; Adapalene; Diagnosis, Differential; Dicarboxylic Acids; Humans; Racial Groups; Rosacea; Skin Pigmentation; Tretinoin | 2022 |
For Mild to Moderate Acne, Adapalene Plus Benzoyl Peroxide, Clindamycin Plus Benzoyl Peroxide, and Adapalene Alone Are Most Effective.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Review of Tretinoin-Benzoyl Peroxide in The Treatment of Acne Vulgaris.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Drug Combinations; Gels; Humans; Immunoglobulin A; Treatment Outcome; Tretinoin | 2022 |
Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Retinoids; Treatment Outcome | 2022 |
Novel and emerging treatment options for acne vulgaris
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Humans; Propionibacterium acnes | 2022 |
From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Gels; Humans; Isotretinoin; Spironolactone; Treatment Outcome | 2023 |
Selective RAR agonists for acne vulgaris: A narrative review.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Humans; Nicotinic Acids; Randomized Controlled Trials as Topic; Receptors, Retinoic Acid; Retinoids; Treatment Outcome; Tretinoin | 2020 |
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Bias; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Erythromycin; Female; Glycolates; Humans; Keratolytic Agents; Male; Mandelic Acids; Niacinamide; Patient Dropouts; Pyruvic Acid; Quality of Life; Salicylic Acid; Sulfur; Tretinoin; Young Adult; Zinc | 2020 |
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Gels; Humans; Network Meta-Analysis; Quality of Life; Treatment Outcome | 2021 |
Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Combined Modality Therapy; Dermatologic Agents; Drug Therapy, Combination; Humans; Lymecycline; Metformin; Tetracycline | 2017 |
Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Benzoyl Peroxide; Dermatologic Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Isotretinoin; Naphthalenes; Time Factors; Treatment Outcome | 2013 |
A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Black or African American; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2014 |
How does our increased understanding of the role of inflammation and innate immunity in acne impact treatment approaches?
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Drug Combinations; Humans; Immunity, Innate; Inflammation | 2016 |
Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Doxycycline; Drug Combinations; Gels; Humans; Inflammation; Isotretinoin | 2016 |
How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Dermatologic Agents; Gels; Humans; Isotretinoin; Nicotinic Acids; Treatment Outcome | 2016 |
In brief: An over-the-counter retinoid for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Dermatologic Agents; Humans; Nonprescription Drugs; Retinoids | 2016 |
A review of adapalene in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Humans; Naphthalenes; Retinoids | 2008 |
Topical retinoids in acne vulgaris: update on efficacy and safety.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Isotretinoin; Naphthalenes; Nicotinic Acids; Retinoids; Safety; Tretinoin | 2008 |
Changing the face of acne therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Age Factors; Clinical Protocols; Dermatologic Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Naphthalenes; Nicotinic Acids; Nonprescription Drugs; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retinoids; Treatment Outcome | 2009 |
The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Randomized Controlled Trials as Topic | 2011 |
Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Benzoyl Peroxide; Child; Dermatologic Agents; Drug Combinations; Gels; Humans; Naphthalenes; Time Factors | 2011 |
Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Black People; Dermatologic Agents; Humans; Naphthalenes; Safety; Skin; Treatment Outcome; White People | 2002 |
Management of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Algorithms; Anti-Bacterial Agents; Benzoyl Peroxide; Contraceptives, Oral; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Dermatologic Agents; Dicarboxylic Acids; Humans; Isotretinoin; Macrolides; Naphthalenes; Nicotinic Acids; Salicylates; Tretinoin; United States | 2003 |
Retinoids: fascinating up-and-coming scenario.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Chemistry, Pharmaceutical; Humans; Isotretinoin; Naphthalenes; Psoriasis; Receptors, Retinoic Acid; Retinoids; Skin Diseases; Tretinoin | 2003 |
Adapalene: a review of its use in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Gels; Humans; Naphthalenes; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Topical retinoids in the management of acne: the best path to clear results.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Humans; Keratolytic Agents; Meta-Analysis as Topic; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Retinoids; Treatment Outcome; Tretinoin; United States | 2004 |
Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Dermatologic Agents; Drug Administration Schedule; Female; Gels; Humans; Male; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Retinoids; Severity of Illness Index; Time Factors; Treatment Outcome; Tretinoin; United States | 2004 |
Spotlight on adapalene in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Drug Administration Schedule; Gels; Humans; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2004 |
Topical tretinoin or adapalene in acne vulgaris: an overview.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Humans; Keratolytic Agents; Naphthalenes; Tretinoin | 2004 |
Acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Drug Therapy, Combination; Erythromycin; Humans; Isotretinoin; Naphthalenes; Tetracycline; Tretinoin; Zinc | 2005 |
Acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythromycin; Humans; Isotretinoin; Minocycline; Naphthalenes; Tetracycline; Tretinoin; Zinc | 2006 |
Defining criteria used to evaluate response to treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Clinical Trials as Topic; Dermatologic Agents; Drug Approval; Humans; Naphthalenes; Outcome Assessment, Health Care; Practice Patterns, Physicians' | 2006 |
Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Drug Therapy, Combination; Humans; Naphthalenes; Practice Guidelines as Topic; Retinoids | 2006 |
Utilizing combination therapy for ethnic skin.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Asian People; Benzoyl Peroxide; Black or African American; Clindamycin; Dermatologic Agents; Dimethylpolysiloxanes; Drug Combinations; Drug Therapy, Combination; Glycerol; Hispanic or Latino; Humans; Hyperpigmentation; Keratolytic Agents; Naphthalenes; Randomized Controlled Trials as Topic; Skin Pigmentation; Tretinoin | 2007 |
Adapalene, a new chemical entity with retinoid activity.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Mice; Naphthalenes; Retinoids | 1993 |
Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Humans; Naphthalenes | 1997 |
Acne vulgaris: a treatment update.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Dicarboxylic Acids; Humans; Hydroxy Acids; Keratolytic Agents; Naphthalenes; Retinoids | 1998 |
Topical treatment of acne vulgaris: retinoids and cutaneous irritation.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Gels; Humans; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Ointments; Retinoids; Tretinoin | 1998 |
Pharmacodynamics and pharmacokinetics of topical adapalene.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Drug Stability; Humans; Models, Biological; Naphthalenes | 1998 |
Adapalene for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Humans; Naphthalenes | 1998 |
[Adapalene--a new retinoid receptor agonist for the treatment of acne vulgaris].
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Humans; Naphthalenes; Receptors, Retinoic Acid | 1998 |
A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Eruptions; Gels; Humans; Keratolytic Agents; Multicenter Studies as Topic; Naphthalenes; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 1998 |
Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Dermatologic Agents; Double-Blind Method; Gels; Keratolytic Agents; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2000 |
Developments in topical retinoid therapy for acne.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Drug Combinations; Humans; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Receptors, Retinoic Acid; Tretinoin; Vitamin A | 2001 |
Current perspectives on the treatment of acne vulgaris and implications for future directions.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Naphthalenes; Prognosis; Retinoids; Severity of Illness Index; Treatment Outcome | 2001 |
Pivotal clinical trials of adapalene in the treatment of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Naphthalenes; Sensitivity and Specificity; Treatment Outcome; Tretinoin | 2001 |
An update of recent clinical trials examining adapalene and acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Naphthalenes; Probability; Treatment Outcome; Tretinoin | 2001 |
The integral role of topical and oral retinoids in the early treatment of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Naphthalenes; Retinoids; Sensitivity and Specificity; Severity of Illness Index; Time Factors; Treatment Outcome | 2001 |
Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Disease Models, Animal; Female; Humans; Male; Mice; Naphthalenes; Sensitivity and Specificity; Treatment Outcome | 2001 |
Trials
111 trial(s) available for adapalene and Acne
| Article | Year |
|---|---|
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Young Adult | 2022 |
Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies.
Topics: Acne Vulgaris; Adapalene; Adult; Dermatologic Agents; Double-Blind Method; Emollients; Humans; Naphthalenes; Retinoids; Treatment Outcome | 2023 |
Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Drug Combinations; Erythema; Gels; Humans; Inflammation; Skin Care; Treatment Outcome | 2023 |
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Humans; Peroxides; Single-Blind Method | 2023 |
Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24 weeks and assessment of atrophic acne scars using three-dimensional image analysis.
Topics: Acne Vulgaris; Adapalene; Adapalene, Benzoyl Peroxide Drug Combination; Administration, Cutaneous; Atrophy; Benzoyl Peroxide; Cicatrix; Connective Tissue Diseases; Dermatologic Agents; Drug Combinations; Gels; Humans; Imaging, Three-Dimensional; Treatment Outcome | 2023 |
A Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Gels; Humans; Quality of Life; Salicylic Acid; Treatment Outcome | 2023 |
Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Gels; Humans; Ketoconazole; Ointments; Tinea Versicolor; Treatment Outcome | 2020 |
A topical gel of tea tree oil nanoemulsion containing adapalene versus adapalene marketed gel in patients with acne vulgaris: a randomized clinical trial.
Topics: Acne Vulgaris; Adapalene; Animals; Dermatologic Agents; Gels; Naphthalenes; Tea Tree Oil; Treatment Outcome | 2022 |
A skincare combined with combination of adapalene and benzoyl peroxide provides a significant adjunctive efficacy and local tolerance benefit in adult women with mild acne.
Topics: Acne Vulgaris; Adapalene; Adult; Benzoyl Peroxide; Emollients; Female; Humans; Lipid Metabolism; Skin; Skin Care | 2017 |
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Nicotinic Acids; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2017 |
Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Adolescent; Adult; Benzoyl Peroxide; Child; Dermatologic Agents; Doxycycline; Drug Compounding; Female; Gels; Humans; Isotretinoin; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Atrophy; Benzoyl Peroxide; Cicatrix; Dermatologic Agents; Double-Blind Method; Drug Combinations; Face; Female; Gels; Humans; Male; Severity of Illness Index; Skin; Treatment Outcome; Young Adult | 2018 |
Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, invest
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Combined Modality Therapy; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Japan; Male; Patient Preference; Quality of Life; Severity of Illness Index; Young Adult | 2018 |
Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Adolescent; Adult; Aminolevulinic Acid; Double-Blind Method; Doxycycline; Female; Humans; Male; Photochemotherapy | 2019 |
Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Salicylic Acid; Treatment Outcome; Young Adult | 2019 |
Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).
Topics: Acne Vulgaris; Adapalene; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Dermatologic Agents; ErbB Receptors; Exanthema; Female; Follow-Up Studies; Gels; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors | 2019 |
Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Naphthalenes; Propionibacterium acnes; Quinolizines; Young Adult | 2013 |
Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Female; Gels; Humans; Hyperpigmentation; Keratolytic Agents; Male; Mexico; Naphthalenes; Pruritus; Tretinoin; Young Adult | 2013 |
Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Inflammation; Male; Naphthalenes; Quality of Life; Severity of Illness Index; Treatment Outcome | 2013 |
Tolerability and irritation potential of four topical acne regimens in healthy subjects.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dapsone; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Naphthalenes; Single-Blind Method | 2013 |
The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Female; Follow-Up Studies; Gels; Humans; In Vitro Techniques; Inflammation; Male; Naphthalenes; Patient Satisfaction; Treatment Outcome; Young Adult | 2013 |
The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Humans; Keratolytic Agents; Naphthalenes; Skin; Treatment Outcome | 2013 |
Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Female; Gels; Humans; Male; Medication Adherence; Naphthalenes; Pilot Projects; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Young Adult | 2014 |
Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Dermatologic Agents; Emollients; Female; Gels; Heparinoids; Humans; Male; Medication Adherence; Naphthalenes; Treatment Outcome; Young Adult | 2014 |
A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Gels; Humans; Isotretinoin; Male; Naphthalenes; Treatment Outcome; Young Adult | 2014 |
A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.
Topics: Acne Vulgaris; Adapalene; Adult; Dermatologic Agents; Dicarboxylic Acids; Female; Gels; Humans; Maintenance Chemotherapy; Severity of Illness Index; Single-Blind Method; Young Adult | 2015 |
A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Anti-Inflammatory Agents; Chalcones; Dermatologic Agents; Double-Blind Method; Female; Gels; Humans; Male; Medication Adherence; Prospective Studies; Skin; Young Adult | 2016 |
Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
Topics: Acne Vulgaris; Adapalene; Adult; Benzoyl Peroxide; Chemistry, Pharmaceutical; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Inflammation; Keratolytic Agents; Male; Treatment Outcome; Young Adult | 2015 |
Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Treatment Outcome; Young Adult | 2016 |
Two Randomized, Double-Blind, Split-Face Studies to Compare the Irritation Potential of Two Topical Acne Fixed Combinations Over a 21-Day Treatment Period.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Clindamycin; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome | 2016 |
Comparison of pneumatic broadband light plus adapalene gel 0.3% versus adapalene gel 0.3% monotherapy in the treatment of mild to moderate acne.
Topics: Acne Vulgaris; Adapalene; Adult; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Male; Monitoring, Physiologic; Patient Compliance; Phototherapy; Treatment Outcome | 2016 |
Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythema; Female; Gels; Humans; Male; Naphthalenes; Nicotinic Acids; Skin; Surveys and Questionnaires | 2008 |
Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythema; Female; Humans; Male; Naphthalenes; Nicotinic Acids; Skin | 2008 |
Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Erythema; Female; Gels; Humans; Male; Naphthalenes; Nicotinic Acids; Retinoids; Skin; Surveys and Questionnaires | 2008 |
Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Microspheres; Naphthalenes; Tretinoin; Young Adult | 2009 |
Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
Topics: Acne Vulgaris; Adapalene; Adult; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Prospective Studies | 2009 |
Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents, Local; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Treatment Outcome; Young Adult | 2009 |
[Pharmacological and clinical profiles of adapalene (Differin) gel 0.1%].
Topics: Acne Vulgaris; Adapalene; Adult; Animals; Dermatologic Agents; Female; Humans; Male; Mice; Naphthalenes | 2009 |
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Canada; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Puerto Rico; Severity of Illness Index; Treatment Outcome; United States; Young Adult | 2009 |
Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Excipients; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Prospective Studies; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Dapsone; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Treatment Outcome; Young Adult | 2010 |
Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Dermatologic Agents; Double-Blind Method; Doxycycline; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Pharmaceutical Vehicles | 2010 |
Efficacy, safety, and tolerability of microsphere adapalene vs. conventional adapalene for acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Dermatologic Agents; Female; Humans; Microspheres; Naphthalenes; Prospective Studies; Young Adult | 2009 |
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Dermatologic Agents; Female; Gels; Humans; Hyperpigmentation; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Severity of Illness Index; Single-Blind Method; Young Adult | 2010 |
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Naphthalenes | 2010 |
Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Microspheres; Naphthalenes; Pilot Projects; Single-Blind Method; Treatment Outcome; Tretinoin; Young Adult | 2010 |
Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Isotretinoin; Male; Naphthalenes; Prospective Studies; Remission Induction | 2011 |
Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Naphthalenes; Severity of Illness Index; Young Adult | 2012 |
A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Dermatologic Agents; Humans; Naphthalenes; Pilot Projects; Treatment Outcome | 2011 |
A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Child; Chronic Disease; Dermatologic Agents; Double-Blind Method; Female; Gels; Humans; Male; Naphthalenes; Secondary Prevention; Treatment Outcome; Young Adult | 2011 |
Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Humans; Lymecycline; Male; Naphthalenes; Patient Satisfaction; Pharmaceutical Vehicles; Treatment Outcome; Young Adult | 2011 |
Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Naphthalenes; Quinolizines; Retinoids; Young Adult | 2011 |
A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Naphthalenes; Patient Satisfaction; Quality of Life; Severity of Illness Index; Young Adult | 2012 |
Multicenter randomized controlled trial on combination therapy with 0.1% adapalene gel and oral antibiotics for acne vulgaris: comparison of the efficacy of adapalene gel alone and in combination with oral faropenem.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Naphthalenes; Time Factors; Treatment Outcome; Young Adult | 2012 |
Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Naphthalenes; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2012 |
Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Asian People; China; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Propylene Glycols; Sodium Dodecyl Sulfate; Young Adult | 2013 |
Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Drug Therapy, Combination; Female; Gels; Humans; Male; Naphthalenes; Quality of Life; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2012 |
Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Patient Satisfaction; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Video Recording; Young Adult | 2012 |
Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Facial Dermatoses; Female; Gels; Humans; Intention to Treat Analysis; Male; Naphthalenes; Patient Preference; Single-Blind Method; Water Loss, Insensible; Young Adult | 2012 |
The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Facial Dermatoses; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Pain; Patient Preference; Pruritus; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Young Adult | 2012 |
A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Diagnostic Self Evaluation; Double-Blind Method; Drug Combinations; Erythema; Female; Humans; Irritants; Keratolytic Agents; Linear Models; Male; Naphthalenes; Pruritus; Skin; Tretinoin; Water Loss, Insensible; Young Adult | 2012 |
Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Female; Gels; Humans; Isotretinoin; Keratolytic Agents; Male; Naphthalenes; Treatment Outcome | 2002 |
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Dermatologic Agents; Double-Blind Method; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Treatment Outcome; Tretinoin | 2001 |
Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Depression; Dermatologic Agents; Female; Humans; Isotretinoin; Male; Middle Aged; Minocycline; Naphthalenes; Quality of Life | 2002 |
Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2003 |
Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lymecycline; Male; Naphthalenes; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2003 |
Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Naphthalenes; Retinoids; Risk Assessment; Single-Blind Method; Skin Irritancy Tests | 2003 |
Single-blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BID) and adapalene 0.1% Gel (QD) in the treatment of acne vulgaris for 11 weeks.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Analysis of Variance; Benzoyl Peroxide; Chi-Square Distribution; Dermatologic Agents; Female; Gels; Humans; Male; Naphthalenes; Single-Blind Method; Treatment Outcome | 2003 |
[The clinical observation of treating acne vulgaris with "xiao cuo fang"].
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Gels; Humans; Male; Naphthalenes; Phytotherapy; Tretinoin | 2004 |
Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Hydrogen Peroxide; Male; Naphthalenes; Oxidants; Prospective Studies; Skin | 2004 |
A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Naphthalenes; Single-Blind Method; Solutions | 2004 |
Benzoyl peroxide, adapalene, and their combination in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Naphthalenes; Patient Satisfaction; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2005 |
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
Topics: Acne Vulgaris; Adapalene; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Ointments; Retinoids; Skin Irritancy Tests | 2005 |
The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Female; Gels; Humans; Male; Naphthalenes; Pharmaceutical Vehicles; Single-Blind Method | 2005 |
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Dose-Response Relationship, Drug; Female; Gels; Humans; Male; Naphthalenes; Treatment Outcome | 2006 |
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Dermatologic Agents; Drug Administration Schedule; Female; Follow-Up Studies; Gels; Humans; Male; Naphthalenes; Severity of Illness Index; Single-Blind Method; Treatment Outcome; United States | 2006 |
The results of the MORE trial: overview.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Chi-Square Distribution; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Prospective Studies; Treatment Outcome | 2006 |
The MORE trial: effectiveness of adapalene gel 0.1% in real-world dermatology practices.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Prospective Studies; Treatment Outcome | 2006 |
Safety and tolerability in the MORE trial.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naphthalenes; Treatment Outcome | 2006 |
Subject preferences for acne treatments containing adapalene gel 0.1%: results of the MORE trial.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Patient Acceptance of Health Care; Treatment Outcome | 2006 |
Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Analysis of Variance; Benzoyl Peroxide; Child; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Female; Humans; Male; Naphthalenes; Ointments; Sebum; Treatment Outcome | 2007 |
Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Isotretinoin; Male; Naphthalenes; Quality of Life; Remission Induction; Sex Factors; Tetracycline; Treatment Outcome | 2007 |
Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Dermatologic Agents; Drug Administration Schedule; Face; Female; Gels; Humans; Male; Naphthalenes; Severity of Illness Index; Treatment Outcome | 2007 |
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naphthalenes; Treatment Outcome | 2007 |
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythema; Female; Gels; Humans; Male; Naphthalenes; Pruritus; Skin; Time Factors; Treatment Outcome | 2007 |
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Topical; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Male; Microspheres; Naphthalenes; Propionibacterium acnes; Severity of Illness Index; Treatment Outcome; Tretinoin | 2007 |
Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Inflammation; Male; Naphthalenes; Retinoids; Skin; Time Factors; Treatment Outcome | 2007 |
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gram-Positive Bacterial Infections; Humans; Male; Naphthalenes; Propionibacterium; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2008 |
Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Female; Gels; Humans; Male; Naphthalenes | 2008 |
Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
Topics: Acne Vulgaris; Adapalene; Adult; Aged; Benzoyl Peroxide; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Combinations; Face; Female; Humans; Male; Middle Aged; Naphthalenes; Treatment Outcome | 2008 |
A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Drug Eruptions; Drug Tolerance; Erythema; Facial Dermatoses; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Pruritus; Single-Blind Method; Skin Diseases; Tretinoin | 1996 |
[Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Time Factors; Tretinoin | 1996 |
Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Naphthalenes; Skin; Treatment Outcome | 1997 |
Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Humans; Keratolytic Agents; Male; Naphthalenes; Skin; Treatment Outcome; Tretinoin | 1997 |
Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Eruptions; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Ointments; Patient Satisfaction; Tretinoin | 1998 |
Adapalene 0.1% gel has low skin irritation potential even when applied immediately after washing.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Gels; Humans; Male; Naphthalenes; Skin Care | 1998 |
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Double-Blind Method; Drug Eruptions; Female; Humans; Keratolytic Agents; Male; Naphthalenes; Quality of Life; Treatment Outcome; Tretinoin | 1998 |
Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations.
Topics: Acne Vulgaris; Adapalene; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Eruptions; Female; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Naphthalenes; Ointments; Tretinoin | 1998 |
Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Double-Blind Method; Drug Eruptions; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Treatment Outcome; Tretinoin | 1998 |
Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Dermatologic Agents; Facial Dermatoses; Humans; Keratolytic Agents; Male; Naphthalenes; Single-Blind Method; Skin; Tretinoin | 1999 |
Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Dermatologic Agents; Double-Blind Method; Female; Gels; Humans; Keratolytic Agents; Male; Naphthalenes; Nicotinic Acids; Treatment Outcome | 2001 |
New photographic techniques for clinical evaluation of acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Female; Fluorescence; Humans; Male; Naphthalenes; Photography; Prospective Studies; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2001 |
A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; China; Dermatologic Agents; Drug Administration Schedule; Female; Follow-Up Studies; Gels; Humans; Male; Naphthalenes; Severity of Illness Index; Treatment Outcome; Tretinoin | 2001 |
Adapalene in the treatment of African patients.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Black People; Dermatologic Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Naphthalenes; South Africa; Treatment Outcome | 2001 |
Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Dermatologic Agents; Female; Humans; Keratolytic Agents; Male; Naphthalenes; Sensitivity and Specificity; Treatment Outcome; Tretinoin | 2001 |
Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Female; Humans; Keratolytic Agents; Male; Naphthalenes; Patient Satisfaction; Treatment Outcome; Tretinoin | 2001 |
Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Naphthalenes; Pharmaceutical Vehicles; Sensitivity and Specificity; Treatment Outcome | 2001 |
Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Female; Humans; Male; Naphthalenes; Office Visits; Patient Satisfaction; Surveys and Questionnaires | 2001 |
Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; China; Female; Humans; Keratolytic Agents; Male; Naphthalenes; Sensitivity and Specificity; Treatment Outcome; Tretinoin | 2001 |
A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Cost-Benefit Analysis; Dermatologic Agents; Double-Blind Method; Facial Dermatoses; Female; Gels; Humans; Male; Naphthalenes; Nicotinic Acids; Ontario; Pennsylvania; Severity of Illness Index; Tennessee; Treatment Outcome | 2002 |
Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Humans; Male; Naphthalenes; Tretinoin | 1991 |
Other Studies
67 other study(ies) available for adapalene and Acne
| Article | Year |
|---|---|
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.
Topics: Acne Vulgaris; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship | 2018 |
Safe Use of Adapalene 0.1 % Gel in a non-Prescription Environment.
Topics: Acne Vulgaris; Adapalene; Animals; Dermatologic Agents; Gels; Naphthalenes; Prescriptions; Rabbits; Rats; Treatment Outcome | 2021 |
Drug repurposing of adapalene for melanoma treatment.
Topics: Acne Vulgaris; Adapalene; Cell Line; Drug Repositioning; Humans; Melanoma | 2022 |
Case of presenile diffuse sebaceous hyperplasia treated with adapalene gel.
Topics: Acne Vulgaris; Adapalene; Adult; Dermatologic Agents; Facial Dermatoses; Gels; Humans; Hyperplasia; Male; Sebaceous Glands; Treatment Outcome | 2022 |
Tretinoin/benzoyl peroxide cream (Twyneo) for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Gels; Humans; Tretinoin | 2022 |
Calcipotriol: A novel tool in treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents; Calcitriol; Dermatologic Agents; Gels; Humans; Prospective Studies; Retinoids; Treatment Outcome | 2022 |
Influence of moisturizer containing licochalcone A, 1,2-decanediol, L-carnitine, and salicylic acid on facial skin lipidome among seborrhea participants.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Carnitine; Dermatitis, Seborrheic; Dermatologic Agents; Gels; Humans; Lipidomics; Lipids; Salicylic Acid; Treatment Outcome | 2022 |
Unraveling the pharmaceutical and clinical relevance of the influence of syringic acid loaded linoleic acid transferosomes on acne.
Topics: Acne Vulgaris; Adapalene; Antioxidants; Clinical Relevance; Gels; Humans; Linoleic Acid; Liposomes | 2023 |
Evaluation of the
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Drugs, Generic; Excipients; Gels; Humans; Skin | 2023 |
Can Adapalene Be Repurposed For Melanoma?
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Gels; Humans; Melanoma; Treatment Outcome | 2023 |
Will the polyphenol and adapalene combination be a good strategy on acne vulgaris?
Topics: Acne Vulgaris; Adapalene; Animals; Anti-Inflammatory Agents; Dermatologic Agents; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Emulsions; Female; Humans; Male; Mice; Nanogels; Polyphenols; Rabbits; Rats; Receptors, Retinoic Acid | 2019 |
Development and Investigation of Vitamin C-Enriched Adapalene-Loaded Transfersome Gel: a Collegial Approach for the Treatment of Acne Vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Animals; Ascorbic Acid; Drug Compounding; Female; Gels; Male; Rats | 2020 |
Acquired idiopathic partial anhidrosis successfully treated with adapalene gel.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Gels; Humans; Hypohidrosis; Naphthalenes; Treatment Outcome | 2020 |
Ion Pair Strategy in Solid Lipid Nanoparticles: a Targeted Approach to Improve Epidermal Targeting with Controlled Adapalene Release, Resulting Reduced Skin Irritation.
Topics: Acne Vulgaris; Adapalene; Amines; Animals; Biological Transport; Delayed-Action Preparations; Dermatologic Agents; Drug Compounding; Drug Liberation; Epidermis; Fatty Acids; Glycerol; Humans; Ions; Nanocapsules; Phase Transition; Skin; Skin Absorption; Swine; Transition Temperature | 2020 |
Preparation and evaluation of adapalene nanostructured lipid carriers for targeted drug delivery in acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Child; Humans; Lipids; Nanostructures; Pharmaceutical Preparations; Young Adult | 2021 |
Subclinical effects of adapalene-benzoyl peroxide: a prospective in vivo imaging study on acne micromorphology and transfollicular delivery.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Gels; Humans; Prospective Studies; Treatment Outcome | 2021 |
Increase adapalene delivery using chemical and herbal enhancers.
Topics: Acne Vulgaris; Adapalene; Humans; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared | 2021 |
An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Humans; Naphthalenes; Treatment Outcome | 2021 |
Mechanistic Analysis of Human Skin Distribution and Follicular Targeting of Adapalene-Loaded Biodegradable Nanospheres With an Insight Into Hydrogel Matrix Influence, In Vitro Skin Irritation, and In Vivo Tolerability.
Topics: Acne Vulgaris; Adapalene; Animals; Caproates; Delayed-Action Preparations; Dermis; Drug Delivery Systems; Epidermis; Hair Follicle; Humans; Hyaluronic Acid; Hydrogel, Polyethylene Glycol Dimethacrylate; Hypromellose Derivatives; Lactones; Nanospheres; Particle Size; Rabbits; Skin Absorption | 2017 |
Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Dermatology; Drug Combinations; Drug Resistance, Bacterial; Humans; Japan; Naphthalenes; Propionibacterium acnes; Societies, Medical; Treatment Outcome | 2018 |
Is maintenance treatment in adult acne important? Benefits from maintenance therapy with adapalene, and low doses of alpha and beta hydroxy acids.
Topics: Acne Vulgaris; Adapalene; Adult; Chronic Disease; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Hydroxy Acids; Male; Recurrence; Severity of Illness Index; Treatment Outcome | 2019 |
Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Animals; Benzoyl Peroxide; Drug Combinations; Female; Gels; Humans; Liposomes; Male; Mice; Propionibacterium acnes; Treatment Outcome | 2018 |
Differin
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Dermatologic Agents; Epidermis; Eyebrows; Female; Hair Removal; Humans | 2019 |
Spironolactone and topical retinoids in adult female cyclical acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Naphthalenes; Retrospective Studies; Severity of Illness Index; Spironolactone; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Acid-responsive polymeric nanocarriers for topical adapalene delivery.
Topics: Acids; Acne Vulgaris; Adapalene; Administration, Cutaneous; Animals; Drug Carriers; Drug Delivery Systems; Hydrogen-Ion Concentration; Nanoparticles; Naphthalenes; Polymers; Skin; Skin Absorption; Swine | 2014 |
Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment.
Topics: Acne Vulgaris; Adapalene; Animals; Drug Stability; Gels; In Vitro Techniques; Nanoparticles; Naphthalenes; Particle Size; Rats, Wistar; Rheology; Skin; Skin Absorption; Static Electricity; Tissue Distribution; Viscosity | 2014 |
Efficacy of 0.1% adapalene in a non-inflammatory Kyoto Rhino Rat acne model.
Topics: Acne Vulgaris; Adapalene; Animals; Cytokines; Disease Models, Animal; Female; Lipid Metabolism; Male; Naphthalenes; Rats | 2014 |
Allergic contact dermatitis caused by adapalene.
Topics: Acne Vulgaris; Adapalene; Dermatitis, Allergic Contact; Dermatologic Agents; Female; Humans; Molecular Structure; Young Adult | 2015 |
Efficacy of adapalene/benzoyl peroxide combination in moderate inflammatory acne and its impact on patient adherence.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Child; Comorbidity; Dermatitis; Dermatologic Agents; Drug Combinations; Female; Germany; Humans; Male; Medication Adherence; Prevalence; Treatment Outcome; Young Adult | 2015 |
Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Dermatitis, Irritant; Drug Combinations; Drug Therapy, Combination; Erythema; Facial Dermatoses; Female; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Time Factors; Young Adult | 2015 |
Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-interv
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Drug Combinations; Drug Therapy, Combination; Facial Dermatoses; Female; Gels; Humans; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Young Adult | 2015 |
A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Animals; Ascorbic Acid; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Drug Synergism; Gels; Lipids; Male; Nanoparticles; Nanostructures; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption | 2016 |
Intradermal and follicular delivery of adapalene liposomes.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Animals; Drug Carriers; Drug Delivery Systems; Drug Stability; Hair Follicle; Liposomes; Particle Size; Permeability; Skin; Skin Absorption; Swine | 2016 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
Topical retinoids for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Humans; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2016 |
Development and characterization of polymeric nanoparticle-based formulation of adapalene for topical acne therapy.
Topics: Acne Vulgaris; Adapalene; Animals; Cell Line; Drug Liberation; Hair Follicle; Humans; Nanospheres; Polymers; Skin; Skin Absorption; Swine | 2017 |
Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non-inflamed atrophic scars in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; alpha-Tocopherol; Anti-Infective Agents; Ascorbic Acid; Atrophy; Benzoyl Peroxide; Chemexfoliation; Cicatrix; Clindamycin; Combined Modality Therapy; Erythema; Female; Glycolates; Humans; Hyperpigmentation; Iontophoresis; Japan; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Male; Microspheres; Minocycline; Naphthalenes; Tretinoin | 2008 |
Intracranial hypertension in a patient using topical adapalene.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Cerebral Arteries; Dermatologic Agents; Female; Headache; Humans; Magnetic Resonance Imaging; Naphthalenes; Papilledema; Pseudotumor Cerebri | 2008 |
Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction.
Topics: Acne Vulgaris; Adapalene; Adolescent; Child; Dermatologic Agents; Drug Therapy, Combination; Humans; Naphthalenes; Nicotinic Acids; Retinoids | 2008 |
Cumulative irritation potential of topical retinoid formulations.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Dermatologic Agents; Female; Humans; Irritants; Naphthalenes; Randomized Controlled Trials as Topic; Skin; Tretinoin | 2008 |
[A fixed combination of adapalene and benzoyl peroxide simplifies acne therapy].
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Clinical Trials as Topic; Dermatologic Agents; Drug Therapy, Combination; Germany; Humans; Naphthalenes; Treatment Outcome | 2008 |
Adapalene-benzoyl peroxide (Epiduo) for acne.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Humans; Naphthalenes; Technology, Pharmaceutical | 2009 |
Benzoyl peroxide and adapalene fixed combination: a novel agent for acne.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Dermatologic Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Naphthalenes | 2009 |
Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Drug Combinations; Drug Synergism; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Young Adult | 2011 |
Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Benzoyl Peroxide; Child; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Mechlorethamine; Naphthalenes; Randomized Controlled Trials as Topic | 2010 |
Local treatment of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Bacterial Agents; Dermatologic Agents; Drug Therapy, Combination; Humans; Naphthalenes; Practice Guidelines as Topic; Retinoids | 2011 |
Maintenance therapy: acne as a chronic disease.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Dermatologic Agents; Female; Humans; Male; Naphthalenes | 2011 |
Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Anti-Bacterial Agents; Asian People; Clindamycin; Cosmetics; Dermatologic Agents; Drug Therapy, Combination; Face; Gels; Humans; Male; Naphthalenes; Severity of Illness Index; Skin; Treatment Outcome | 2012 |
Ex vivo demonstration of a synergistic effect of Adapalene and benzoyl peroxide on inflammatory acne lesions.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; beta-Defensins; Cell Differentiation; Cell Proliferation; Dermatologic Agents; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Immunohistochemistry; In Vitro Techniques; Integrins; Male; Naphthalenes; Young Adult | 2011 |
Treatment of severe acne with low-dose isotretinoin.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Female; Humans; Isotretinoin; Male; Naphthalenes; Photography; Retrospective Studies; Severity of Illness Index | 2012 |
A split-faced, observer-blinded comparison study of topical adapalene/benzoyl peroxide and adapalene in the treatment of Asian acne patients.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Asian People; Benzoyl Peroxide; Dermatologic Agents; Drug Combinations; Face; Female; Humans; Irritants; Keratolytic Agents; Male; Naphthalenes; Patient Compliance; Skin; Young Adult | 2013 |
The MORE trial: relevance to everyday dermatology practices.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Clinical Trials, Phase IV as Topic; Cost of Illness; Dermatologic Agents; Drug Therapy, Combination; Guideline Adherence; Humans; Naphthalenes; Practice Guidelines as Topic; Prevalence; Quality of Life; United States | 2006 |
Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Colonic Neoplasms; Dermatologic Agents; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Isotretinoin; Lung Neoplasms; Male; Middle Aged; Minocycline; Naphthalenes | 2007 |
In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions.
Topics: Acne Vulgaris; Adapalene; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD1; Antigens, CD1d; Biopsy; Cells, Cultured; Humans; Immunohistochemistry; In Vitro Techniques; Interleukin-10; Naphthalenes; Skin; Toll-Like Receptor 2 | 2007 |
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
Adapalene for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Double-Blind Method; Erythema; Humans; Male; Naphthalenes; Pruritus | 1997 |
A new concept of drug delivery for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Gels; Humans; In Vitro Techniques; Naphthalenes; Skin | 1998 |
[Pharma-Clinics. The drug of the month. Adapalene (Differin gel)].
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Drug Combinations; Humans; Irritants; Naphthalenes; Retinoids; Skin; Time Factors | 1998 |
A new topical retinoid--why a new topical acne therapy?
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Drug Resistance; Gels; Humans; Naphthalenes; Retinoids | 1998 |
Pharmacology of adapalene.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Division; Dermatologic Agents; Drug Interactions; HeLa Cells; Humans; Keratinocytes; Naphthalenes; Receptors, Cytoplasmic and Nuclear; Skin; Tretinoin | 1998 |
A is for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Female; Humans; Isotretinoin; Male; Middle Aged; Naphthalenes; Recurrence; Tretinoin | 1999 |
Polarized light photography and videomicroscopy greatly enhance the capability of estimating the therapeuic response to a topical retinoid (adapalene) in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Female; Humans; Light; Male; Microscopy, Video; Naphthalenes; Photography; Sensitivity and Specificity; Treatment Outcome | 2001 |
Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Humans; Male; Naphthalenes; South Africa; Treatment Outcome | 2001 |
Adapalene in clinical practice.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Humans; Naphthalenes | 2001 |
Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Animals; Biopsy; Disease Models, Animal; Epidermis; Female; Image Processing, Computer-Assisted; Male; Mice; Mice, Hairless; Naphthalenes; Retinoids | 1991 |
Follicular penetration and distribution of topically applied CD 271, a new naphthoic acid derivative intended for topical acne treatment.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Naphthalenes; Rats | 1990 |